Status:
COMPLETED
Effective Ads for Quitting Smoking
Lead Sponsor:
UNC Lineberger Comprehensive Cancer Center
Collaborating Sponsors:
Food and Drug Administration (FDA)
National Institute on Drug Abuse (NIDA)
Conditions:
Smoking Behaviors
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The main purpose of this trial is to identify effective quit smoking ads for people who smoke menthol cigarettes. Investigators will conduct an online randomized trial with a nationally representative...
Detailed Description
This trial will evaluate the effectiveness of efficacy-based quit smoking ads in a 5 (theme) x 6 (ad) mixed factorial randomized design. Recruitment: A survey company will recruit \~1,400 participant...
Eligibility Criteria
Inclusion
- This national trial is not open to enrollment from the general public. Participation is restricted to individuals who meet the following inclusion and exclusion criteria:
- Inclusion Criteria
- Currently smoke menthol cigarettes
- Be a member of the AmeriSpeak online survey panel or their convenience sample
- Live in the US
- Be age 21 years or older
- Read and speak English
- Exclusion Criteria
- Not currently smoke menthol cigarettes
- Not be a member of the AmeriSpeak online survey panel or their convenience sample
- Not live in the US
- Be younger than age 21 years
- Not be able to read and speak English
Exclusion
Key Trial Info
Start Date :
September 5 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 21 2024
Estimated Enrollment :
1236 Patients enrolled
Trial Details
Trial ID
NCT06485479
Start Date
September 5 2024
End Date
October 21 2024
Last Update
November 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina
Chapel Hill, North Carolina, United States, 27599